Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermadrop, a brand of Meddrop GmbH, is a German medical technology company specializing in non-invasive transdermal delivery systems. The company's core innovation is the TDA (Transdermal Application) platform, which utilizes high-pressure oxygen to transport active ingredients into deep dermal layers without needles. This technology allows for the delivery of substances like hyaluronic acid, peptides, and vitamins through the skin barrier into the dermis. Dermadrop serves the aesthetic, dermatological, and veterinary markets with a range of specialized cartridges and delivery devices. Their products are designed to treat various skin conditions, including aging, acne, and hair loss, while providing a pain-free alternative to traditional injections. The company operates globally, providing solutions for both professional clinics and high-end spa environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DERMADROP.